Business
Groupe Athena, Inc. Continues Record Revenue Growth With Strongest Quarter To Date
Groupe Athena, Inc. Continues Record Revenue Growth With Strongest Quarter To Date.
About this update from Ayujoy Herbals Ltd.
[{"type":"text","content":"\n\n\n\n\n\n\n\nGroupe Athena, Inc. Continues Record Revenue Growth With Strongest Quarter To Date\n\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:\"0in\";\n}\n\n\n\n\n\n\n\n\n\n\nGroupe Athena, Inc. Continues Record Revenue Growth With Strongest Quarter To Date\n\nPR Newswire\n\nMUMBAI, India, Feb. 12, 2013\n\n\n\n\n\n\n\nMUMBAI, India, Feb. 12, 2013 /PRNewswire/ -- Groupe Athena, Inc. (OTCPink: GATA) announced today record revenues of $14,810,936 for the period ending December 31, 2012, which represents a 23% increase over the same period in 2011. Net after tax income for the period was $1,549,882 or $.033 per share which was also the best for any quarter to date as profit margins continue to increase.\n\n\nRevenue growth for the first half of this fiscal year is also on a record pace and has increased approximately 30% year on year. With the two recent strong quarters trailing twelve month (ttm) earnings have increased to just over $.11 per share. \n\n\nCash reserves are strong and long term debt remains virtually non-existent as the Company prepares to outfit it's recently purchased new testing facility. The company reports it is still committed to funding all capital expenditures entirely from internal cash accruals without any shareholder dilution or debt increases. \n\n\nCompany Chairman, D. Purohit stated, \"We could not be happier with our financial position and the pharmaceutical business environment in general. Many of our regional customers are now renewing contracts going forward and our efforts to develop and expand our global footprint is progressing nicely.\" \n\n\nAs previously stated, the company plans to apply for listing on the NASDAQ Bulletin Board quotation system with the completion of the audit for this fiscal year ending June 30, 2013. \n\n\nTo review the complete quarterly report please go to www.otcmarkets.com/stock/GATA/quote and click on \"Financials\".\n\n\nAs was previously stated, the Indian pharmaceutical industry is increasingly focusing on exports to the United States and GATA is well positioned to help them get their products approved by the FDA for sale...